This ratio of down-regulation of hepatic miR-122 was more profound and significant in CHC patients with higher ALT levels, increased necroinflammation, and fibrosis compared with those with comparatively lower ALT levels and with little, or moderate, liver damage. This evidence concerns the gene GPT and cryohydrocytosis.